117516-88-8

Basic information

• Product Name: ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate
• Synonyms: ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate;UKRORGSYN-BB BBV-025612;ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate(SALTDATA: FREE)
• CAS NO: 117516-88-8
• Molecular Formula: C₁₂H₁₂N₂O₂S
• Molecular Weight: 248.3
• Mol File: 117516-88-8.mol

Chemical Properties

• Boiling Point: 399.8°C at 760 mmHg
• Flash Point: 195.6°C
• Appearance: /
• Density: 1.279g/cm³
• Vapor Pressure: 1.33E-06mmHg at 25°C
• Refractive Index: 1.617
• CAS DataBase Reference: ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate(117516-88-8)
• EPA Substance Registry System: ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate(117516-88-8)

Safety Data

• Hazardous Substances Data: 117516-88-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate is used as a reagent for the synthesis of 2-aminothieno[2,3-d][1,3]thiazin-4-ones, which have weak anti-allergic effects. This makes it a valuable component in the development of pharmaceuticals aimed at treating allergic reactions and related conditions.
Used in Chemical Synthesis:
In the field of chemical synthesis, ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate is utilized as a key intermediate in the preparation of various organic compounds. Its unique structure allows for the formation of diverse chemical entities, making it a versatile building block in organic chemistry.
Used in Research and Development:
Ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate is also employed in research and development settings, where it can be used to explore new chemical reactions, investigate the properties of related compounds, and develop novel applications for this class of organic compounds. Its potential in various fields makes it an interesting subject for scientific inquiry and innovation.

InChI:InChI=1/C12H12N2O2S/c1-2-16-12(15)10-9(7-17-11(10)13)8-3-5-14-6-4-8/h3-7H,2,13H2,1H3

Upstream product

• 1122-54-9 methyl (4-pyridyl) ketone 
• 105-56-6 ethyl 2-cyanoacetate 

Downstream Products

• 117516-90-2 2-(3-Benzoyl-thioureido)-4-pyridin-4-yl-thiophene-3-carboxylic acid ethyl ester 
• 692889-16-0 4-(pyridin-4-yl)thiophen-2-ylamine 

Relevant articles and documents

Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis

Inhibition of angiogenesis is a promising strategy for the treatment of cancer. Herein, we describe the design and synthesis of thieno[2,3-d]pyrimidine-1,3,4-thiadiazole-aryl urea derivatives 11a-m to evaluate their efficacy in the chick chorioallantoic membrane (CAM) assay. Among target agents, 11i had a considerable activity against prostate cancer cell line, PC3 (IC50 = 3.6 μM). Moreover, induction of apoptosis, good inhibitory activity against the growth of capillary blood vessels, and inhibition of VEGFR-2 phosphorylation were noticeable parameters which convinced us that 11i could be considered as a promising candidate for the discovery of novel drugs to treat tumors, particularly prostate cancer.

Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors

The Rho kinases (ROCK1 and ROCK2) are highly homologous serine/threonine kinases that act on substrates associated with cellular motility, morphology, and contraction and are of therapeutic interest in diseases associated with cellular migration and contraction, such as hypertension, glaucoma, and erectile dysfunction. Beginning with compound 4, an inhibitor of ROCK1 identified through high-throughput screening, systematic exploration of SAR, and application of structure-based design, led to potent and selective ROCK inhibitors. Compound 37 represents significant improvements in inhibition potency, kinase selectivity, and CYP inhibition and possesses pharmacokinetics suitable for in vivo experimentation.

Novel 4-oxothienopyrimidinyl propanoic acid derivatives as AMPactivated protein kinase (AMPK) activators

Adenosine 5′-monophosphate (AMP) activated protein kinase (AMPK) is a highly conserved sensor of cellular energy. AMPK has been recognized as a key regulator of mammalian metabolic function and has emerged as an attractive target for the treatment of meta

HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF

The present invention provides a novel amide compound represented by the following formula, which has a matrix metalloproteinase inhibitory activity and is useful as a pharmaceutical agent. wherein each symbol is as defined in the specification.

COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES

The present invention relates to substitute thiazole and thiophene derivatives useful as inhibitors of rock and other protein kinaeses. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders, including proliferative, cardiac and neurodegenerative diseases.